Liza Makowski Hayes
#136,850
Most Influential Person Now
American nutritional biochemist
Liza Makowski Hayes's AcademicInfluence.com Rankings
Liza Makowski Hayesmedical Degrees
Medical
#3626
World Rank
#4110
Historical Rank
Nutrition
#153
World Rank
#163
Historical Rank
Liza Makowski Hayesbiology Degrees
Biology
#15062
World Rank
#18967
Historical Rank
Biochemistry
#2671
World Rank
#2853
Historical Rank
Download Badge
Medical Biology
Liza Makowski Hayes's Degrees
- PhD Nutritional Biochemistry University of California, Berkeley
- Masters Nutrition University of California, Berkeley
- Bachelors Biochemistry University of California, Berkeley
Why Is Liza Makowski Hayes Influential?
(Suggest an Edit or Addition)According to Wikipedia, Liza Makowski Hayes is an American nutritional biochemist. As a professor at the University of Tennessee, her research focuses on how metabolic stress and inflammation alters the progression of diseases, specifically obesity and cancer.
Liza Makowski Hayes's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis (2001) (657)
- Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2 (2007) (636)
- The inflammation highway: metabolism accelerates inflammatory traffic in obesity (2012) (508)
- Cafeteria Diet Is a Robust Model of Human Metabolic Syndrome With Liver and Adipose Inflammation: Comparison to High-Fat Diet (2011) (498)
- Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis (2009) (461)
- Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. (2017) (460)
- Metabolic Reprogramming of Macrophages (2014) (399)
- The Fatty Acid-binding Protein, aP2, Coordinates Macrophage Cholesterol Trafficking and Inflammatory Activity (2005) (300)
- Fatty acid binding proteins--the evolutionary crossroads of inflammatory and metabolic responses. (2004) (251)
- Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors. (2018) (234)
- Role of the fatty acid binding protein mal1 in obesity and insulin resistance. (2003) (199)
- Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice. (1999) (194)
- The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis (2005) (185)
- Combined Adipocyte-Macrophage Fatty Acid–Binding Protein Deficiency Improves Metabolism, Atherosclerosis, and Survival in Apolipoprotein E–Deficient Mice (2004) (182)
- The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. (2005) (178)
- Adipocyte Fatty Acid–Binding Protein, aP2, Alters Late Atherosclerotic Lesion Formation in Severe Hypercholesterolemia (2002) (172)
- Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release (2018) (164)
- DiffSplice: the genome-wide detection of differential splicing events with RNA-seq (2012) (147)
- Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma (2012) (144)
- Immunometabolism: From basic mechanisms to translation (2020) (133)
- Contribution of Adipose Tissue to Development of Cancer. (2017) (132)
- Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis. (2006) (121)
- Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer (2014) (118)
- Metabolic profiling of PPARα−/− mice reveals defects in carnitine and amino acid homeostasis that are partially reversed by oral carnitine supplementation (2009) (112)
- Metabolomic Profiling Reveals Mitochondrial-Derived Lipid Biomarkers That Drive Obesity-Associated Inflammation (2012) (111)
- Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression (2012) (102)
- Basal-like Breast Cancer Cells Induce Phenotypic and Genomic Changes in Macrophages (2012) (96)
- Obesity, metabolism and the microenvironment: Links to cancer (2013) (96)
- Impact of Tumor Microenvironment and Epithelial Phenotypes on Metabolism in Breast Cancer (2012) (88)
- Metabolic reprogramming through fatty acid transport protein 1 (FATP1) regulates macrophage inflammatory potential and adipose inflammation (2016) (87)
- Myeloid Slc2a1-Deficient Murine Model Revealed Macrophage Activation and Metabolic Phenotype Are Fueled by GLUT1 (2019) (72)
- Tumor Intrinsic Subtype Is Reflected in Cancer-Adjacent Tissue (2014) (70)
- The Cytochrome P450 Epoxygenase Pathway Regulates the Hepatic Inflammatory Response in Fatty Liver Disease (2014) (67)
- Role of LKB1 in lung cancer development (2008) (62)
- Factor XIIIA—expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking (2018) (56)
- Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis (2020) (53)
- High XRCC1 Protein Expression Is Associated with Poorer Survival in Patients with Head and Neck Squamous Cell Carcinoma (2011) (52)
- Role of HGF in epithelial–stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ (2013) (48)
- Obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancer. (2014) (48)
- Distinct microbial communities that differ by race, stage, or breast-tumor subtype in breast tissues of non-Hispanic Black and non-Hispanic White women (2019) (46)
- Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancer (2013) (39)
- Cafeteria diet-induced obesity causes oxidative damage in white adipose. (2016) (37)
- Friend or Foe? Recent Strategies to Target Myeloid Cells in Cancer (2020) (35)
- Reversal of obesity-driven aggressiveness of endometrial cancer by metformin. (2017) (30)
- Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti‐tumor immunity (2020) (30)
- Adipose inflammation and macrophage infiltration after binge ethanol and burn injury. (2014) (29)
- Genistein effects on stromal cells determines epithelial proliferation in endometrial co-cultures. (2011) (26)
- Weight Loss Reversed Obesity-Induced HGF/c-Met Pathway and Basal-Like Breast Cancer Progression (2014) (26)
- Association between differential gene expression and body mass index among endometrial cancers from The Cancer Genome Atlas Project. (2016) (26)
- SigFuge: single gene clustering of RNA-seq reveals differential isoform usage among cancer samples (2014) (24)
- The Fatty Acid-binding Protein, aP2, Coordinates Macrophage Cholesterol Trafficking and Inflammatory Activity: MACROPHAGE EXPRESSION OF aP2 IMPACTS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR γ AND I κ B KINASE ACTIVITIES* (2012) (23)
- Nutrition and metabolic correlates of obesity and inflammation: clinical considerations. (2015) (21)
- Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer (2021) (20)
- Gene-by-environment modulation of lifespan and weight gain in the murine BXD family (2021) (16)
- Obesity-Mediated Regulation of HGF/c-Met Is Associated with Reduced Basal-Like Breast Cancer Latency in Parous Mice (2014) (15)
- Weight loss reduces basal-like breast cancer through kinome reprogramming (2016) (15)
- Stability of human plasma leptin concentrations within 36 hours following specimen collection. (1999) (15)
- Lipoprotein profiles, not anthropometric measures, correlate with serum lipoprotein(a) values in children: the Taipei children heart study (2004) (15)
- Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr-/- mice. (2017) (14)
- cMET inhibitor crizotinib impairs angiogenesis and reduces tumor burden in the C3(1)-Tag model of basal-like breast cancer (2016) (14)
- FTY720 Regulates Mitochondria Biogenesis in Dendritic Cells to Prevent Kidney Ischemic Reperfusion Injury (2020) (12)
- Gene-by-environmental modulation of longevity and weight gain in the murine BXD family (2019) (11)
- Increased efficacy of metformin corresponds to differential metabolic effects in the ovarian tumors from obese versus lean mice (2017) (9)
- Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression (2021) (9)
- A conditional mouse expressing an activating mutation in NRF2 displays hyperplasia of the upper gastrointestinal tract and decreased white adipose tissue (2020) (9)
- Metabolism fine-tunes macrophage activation (2016) (9)
- Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis (DOI:10.1016/j.cmet.2006.02.010) (2006) (7)
- TGF-β Alters the Proportion of Infiltrating Immune Cells in a Pancreatic Ductal Adenocarcinoma (2021) (6)
- Glucose metabolism is linked to the inflammatory status of macrophages (2012) (5)
- TRPV6 channel mediates alcohol-induced gut barrier dysfunction and systemic response (2021) (4)
- The Cytochrome P 450 Epoxygenase Pathway Regulates the Hepatic Inflammatory Response in Fatty Liver Disease (2014) (4)
- The pancreatic cancer immune tumor microenvironment is negatively remodeled by gemcitabine while TGF‐β receptor plus dual checkpoint inhibition maintains antitumor immune cells (2022) (3)
- Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore (2022) (3)
- Response to immune checkpoint blockade improved in pre-clinical model of breast cancer after bariatric surgery (2022) (3)
- Factor XIIIA—expressing inflammatory monocytes promote lung squamous cancer through fibrin cross-linking (2018) (3)
- Abstract P6-02-09: Role of HGF in obesity-associated tumorigenesis: C3(1)-Tag mice as a model for human basal-like breast cancer (2012) (3)
- PKC agonism restricts innate immune suppression, promotes antigen cross-presentation and synergizes with agonistic CD40 antibody therapy to activate CD8+ T cells in breast cancer (2022) (2)
- Biological effects of metformin in a preoperative window clinical trial for endometrial cancer (2014) (2)
- Abstract 2919: Novel pre-clinical model to identify genetic modifiers of triple negative breast cancer (2021) (1)
- Abstract number 11: Metformin had increased efficacy under obese conditions in a novel genetically engineered mouse model of serous ovarian cancer (2014) (1)
- Molecular and metabolic differences of treatment responders versus non-responders in a phase 0 clinical trial of metformin in endometrial cancer. (2015) (1)
- Intestinal fungi as regulators of obesity and glucose tolerance (2020) (1)
- Increased efficacy of metformin corresponds to differential metabolic effects in ovarian tumors in obese versus lean mice (2016) (1)
- Mitochondrial Role in Oncogenesis and Potential Chemotherapeutic Strategy of Mitochondrial Infusion in Breast Cancer (2022) (1)
- Abstract 4871: Obesity-mediated regulation of HGF/c-Met and reduced basal-like breast cancer latency in parous mice (2014) (1)
- Metformin has increased efficacy under obese conditions in a novel genetically engineered mouse model of serous ovarian cancer (2014) (1)
- Abstract 4371: Integrated molecular characterization of pheochromocytoma and paraganglioma including a novel, recurrent and prognostic fusion gene (2016) (1)
- The role of obesity and bariatric surgery-induced weight loss in breast cancer (2022) (1)
- Protein Kinase C Delta Regulates Mononuclear Phagocytes and Hinders Response to Immunotherapy in Cancer (2022) (1)
- Abstract 118: Myeloid PKCd activation inhibits innate immune suppression and promotes antigen cross-presentation in triple negative breast cancer (2021) (0)
- Adipose inflammation induced by acute alcohol exposure and burn trauma (2012) (0)
- byinhibitingfatty-acid-bindingproteinaP2 (2007) (0)
- Myeloid cells in the era of cancer immunotherapy: Top 3 unanswered questions. (2023) (0)
- Fatty acid transport protein 1 mediates macrophage eicosanoid metabolism (2013) (0)
- Abstract 175: Lack of Macrophage GLUT1-Mediated Glucose Metabolism Increases Atherosclerotic Lesion Instability (2015) (0)
- Diet-induced obesity increases tumor aggressiveness in a genetically engineered mouse model of serous ovarian cancer (2013) (0)
- Role of HGF in epithelial–stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ (2013) (0)
- Abstract IA45: Obesity and the microenvironment in basal-like breast cancer (2015) (0)
- Abstract 3113: Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in a genetically engineered mouse model of serous ovarian cancer (2014) (0)
- Abstract PS17-46: Pkc agonism restricts immune suppression and promotes antigen cross-presentation in triple negative breast cancer (2021) (0)
- Erratum: Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis (2010) (0)
- Myeloid‐specific Glut1 Ablation Attenuates Mammary Gland Inflammation and Claudin‐low Breast Cancer Progression (2018) (0)
- Fatty acid transport protein mediates macrophage polarization (2012) (0)
- Alcohol Exposure and Burn Injury Drive Acute Adipose Inflammation and Alterations in Glucose Transporter GLUT1 (2012) (0)
- Abstract 102: Ferrichrome suppresses pancreatic tumor growthviatargeting TAMs and enhancing CD8+ T-cells infiltration (2019) (0)
- Weight loss reduces basal-like breast cancer through kinome reprogramming (2016) (0)
- Relationship between Body Mass Index (BMI) and gene expression profiles of high grade serous ovarian cancers in The Cancer Genome Atlas (TCGA) project (2015) (0)
- Obesity-driven metabolic effects differ in ovarian vs endometrial cancer (2017) (0)
- Metabolomic Profiling Reveals Pro‐Inflammatory Lipid Biomarkers Associated with Obesity (2011) (0)
- Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma Graphical (0)
- What Health Care Providers Know and How They Communicate Breast Cancer Risk to Patients (2017) (0)
- Abstract 2974: Obesity-induced modifications in the mammary gland microenvironment promote TNBC progression even after weight loss (2017) (0)
- Title: Response to immune checkpoint blockade improved in pre-clinical model of breast cancer (0)
- Abstract PS17-29: Surgically induced weight loss corrects obesity associated tumor progression and improves responsiveness to immunotherapy (2021) (0)
- PKC AGONISM RESTRICTS INNATE IMMUNE SUPPRESSION, PROMOTES ANTIGEN CROSS-PRESENTATION AND SYNERGIZES WITH AGONISTIC CD40 THERAPY IN BREAST CANCER (2021) (0)
- Molecular and metabolic differences of treatment responders versus nonresponders in a phase 0 clinical trial of metformin in endometrial cancer (2015) (0)
- Abstract 102: Ferrichrome suppresses pancreatic tumor growth via targeting TAMs and enhancing CD8+ T-cells infiltration (2019) (0)
- G‐protein‐Coupled Bile Acid Receptor Attenuates Liver Injury in a Murine Model of Acute Parenteral Nutrition (2018) (0)
- Obesity increases carcinogenesis in a mouse model of basal‐like breast cancer (BLBC) (2011) (0)
- Differential gene expression was associated with increasing body mass index (BMI) among endometrial cancers from The Cancer Genome Atlas (TCGA) Project (2014) (0)
- Obesity exposure across the lifespan leads to increased tumor growth in a genetically engineered mouse model of serous ovarian cancer (2016) (0)
- Differential proteomic analysis of metformin response in a preoperative-window clinical trial for endometrial cancer (2017) (0)
- Nutrition and Metabolic Correlates of Obesity and Inflammation: Clinical Considerations 1–3 (2015) (0)
- Impact of stromal microenvironment on metabolic phenotypes in breast cancer: evidence for stroma-influenced Warburg effect (2012) (0)
- The effect of TGF-β on PD-L1 expression on PDAC TAMs. (2020) (0)
- Abstract 4090: Metabolic and microenvironment changes in the mammary of calorie restricted, normal weight, and obese mice throughout the lifespan (2016) (0)
- Fr642 TGF-β RECEPTOR INHIBITION ENHANCES DUAL-IMMUNE CHECKPOINT INHIBITION THERAPY IN PANCREATIC CANCER (2021) (0)
- Abstract 502: Characterizing breast cancer subtype-specific responses to macrophages. (2013) (0)
- Abstract P4-04-28: Weight loss reversed the carcinogenic effect of obesity on basal-like breast cancer (2015) (0)
- Impact of tumor and epithelial phenotypes on metabolism in breast cancer (2013) (0)
- Abstract 5040: Weight loss prevents obesity-associated basal-like breast cancer progression: Role of hepatocyte growth factor/c-Met (2014) (0)
- Abstract LB-183: Anti-PD1 blunts obesity associated triple negative breast cancer progression (2019) (0)
- 682 PKC agonism restricts innate immune suppression, promotes antigen cross-presentation and synergizes with agonistic CD40 therapy in breast cancer (2021) (0)
- Abstract PS17-04: Immune checkpoint blockade reprograms tumor microenvironment and systemic immune landscape in obesity associated triple negative breast cancer (2021) (0)
This paper list is powered by the following services:
Other Resources About Liza Makowski Hayes
What Schools Are Affiliated With Liza Makowski Hayes?
Liza Makowski Hayes is affiliated with the following schools:
